Warning message

ARCHIVED CONTENT: Persons using assistive technology may not be able to fully access information in this file. For assistance, please send an email to niaic@nia.nih.gov or call us at 1-800-222-2225.
About NIA

NACA meeting: January 25–26, 2011

Legislative Update

FY2011 Labor, Health and Human Services, Education and Related Agencies Appropriations - The federal government is currently funded under a continuing resolution (C.R.) through March 4, 2011. Funding for the NIH Cures Action Network (CAN) to “conduct and support "revolutionary advances" in translating scientific discoveries from bench to bedside.” authorized in P.L. 111-148, the Patient Protection and Affordability Act, was not included in the enacted C.R. The House passed H.R. 3082, for full-year funding that failed, did include $12 million for CAN. (See NIA Budget Report).

New Department of Health and Human Services Legislation Enacted: S. 3036/H.R. 4689, the National Alzheimer’s Project Act (NAPA) was introduced by Senators Evan Bayh (D-IN) and Susan Collins (R-ME) and Representative Ed Markey (D-MA). S. 3036, the National Alzheimer’s Project Act, as amended by a manager’s amendment, was passed by the Senate and House in December.  It now goes to the President for signature into public law.

  • Establishes a National Alzheimer’s Project, within the Office of the Secretary,
  • Creates and maintains an integrated national plan to overcome Alzheimer’s; provide information on coordination of Alzheimer’s research across all federal agencies;
  • Accelerates the development of new treatments;
  • Ensures inclusion of ethnic and racial populations at high risk of Alzheimer’s;
  • Coordinates a global fight against the disease, and ;
  • Establishes an advisory council with representatives from several federal agencies, including the NIH, along with non-federal stakeholders to advise the Secretary or her designee on the Alzheimer’s Project

White House Sponsored- Events and Congressional Briefings and Hearings:

  • On Dec. 9, 2010, House Energy and Commerce Subcommittee on Health held a hearing on Alzheimer's Disease Challenges. Dr. Marcelle Morrison-Bogorad, Director of NIA Neuroscience presented testimony on Alzheimer’s disease research at NIH. 
  • On November 18, Dr. Richard Hodes, Director of NIA, participated in briefings sponsored by the Friends of NIA, Alliance for Aging Research and USAgainstAD for House and Senate staff on aging-related and Alzheimer’s disease research.  Drs. Marcelle Morrison-Bogorad, Director, Division of Neuroscience, Neil Buckholtz, Chief, Dementias of Aging Branch, Division of Neuroscience, Creighton Phelps, Director, Alzheimer’s Disease Centers Programs, Division of Neuroscience, and Richard Suzman, Director, Behavioral and Social Research, NIA, also participated in a post-briefing discussion session. 
  • On November 10, majority staff of the Senate Committee on Aging visited NIH to learn more about NIA research activities and other NIH research important to older Americans.  NIH Participants included Dr. Richard Hodes, Director, and Dr. Richard Suzman, Director, Division of Behavioral and Social Research, NIA; Dr. Patricia Grady, Director of NINR; Dr. Anthony Hayward, Division for Clinical Research Resources, NCRR; and Dr. Sally Rockey, NIH Deputy Director for Extramural Research.  Laura Lee, Special Assistant to the Clinical Center Deputy Director, gave the group a tour of the Mark O. Hatfield Clinical Research Center.
  • On September 21, Dr. Hodes participated on the “State of the Science Panel” at the World AD Day sponsored by the White House.

International Research Visits and Events.

As global aging continues to be recognized, requests for talks and visits to NIA from other countries for information and consultation also continue.  Recent international events include:

  • October 12, Healthy Aging Globally: A Life Cycle Approach held at the Italian Embassy. Dr. Richard Hodes presented NIH/NIA aging research update.
  • Dr. Hiroo Imura, Presidential Advisor on Health Research and Director of the Center for Research and Development Strategy (CRDS), Japan Science & Technology Agency (JST), and colleagues discussion led by Dr. Marie Bernard, Deputy Director
  • Mr. Woon Tae Hyung, Ministry of Health and Welfare, Republic of Korea, and colleagues discussion led by Dr. Marie Bernard, Deputy Director

Submitted by:
Tamara Jones, Ph.D.
Legislative Officer
National Institute on Aging